देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
BETAINE
RECORDATI RARE DISEASES CANADA INC
A16AA06
BETAINE
1G
POWDER FOR SOLUTION
BETAINE 1G
ORAL
180G
Prescription
OTHER MISCELLANEOUS THERAPEUTIC AGENTS
Active ingredient group (AIG) number: 0134220001; AHFS:
APPROVED
2010-04-07
PRODUCT MONOGRAPH Pr Cystadane ® betaine anhydrous powder for oral solution 1 gram/1.7 cc scoop Professed Standard Anti-Homocysteine Agent Recordati Rare Diseases Canada Inc. 3080 Yonge Street, Suite 6060 Toronto, ON M4N 3N1 Distributed by: Recordati Rare Diseases Canada Inc. Oakville, ON L6M 2W2 Date of Revision: April 10, 2018 Submission Control No: 213241 _Cystadane_ _®_ _ Product Monograph _ _Page 2 of 19_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ....................................................................................................6 DRUG INTERACTIONS ....................................................................................................7 DOSAGE AND ADMINISTRATION ................................................................................7 OVERDOSAGE ..................................................................................................................8 ACTION AND CLINICAL PHARMACOLOGY ..............................................................9 STORAGE AND STABILITY ..........................................................................................10 SPECIAL HANDLING INSTRUCTIONS .......................................................................10 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................11 PART II: SCIENTIFIC INFORMATION ...............................................................................12 PHARMACEUTICAL INFORMATION ........................................................ पूरा दस्तावेज़ पढ़ें